Prognostic Factors for Combined Ranibizumab and Prompt Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy.
Sign Up to like & getrecommendations! Published in 2019 at "Photodiagnosis and photodynamic therapy"
DOI: 10.1016/j.pdpdt.2019.06.004
Abstract: PURPOSE To investigate the prognostic factors for the combined therapy of ranibizumab and prompt verteporfin photodynamic therapy (vPDT) for eyes with polypoidal choroidal vasculopathy (PCV). METHODS Sixty-two PCV eyes of 62 patients that received the… read more here.
Keywords: photodynamic therapy; prognostic factors; factors combined; therapy ... See more keywords
Predictive factors for combined anti-PD-1 and anti-angiogenic therapy in multiline treatment of advanced non-small cell lung cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e15059
Abstract: e15059Background: Immune checkpoint inhibitors (ICIs), such as PD-1/ PD-L1 inhibitors, have made a significant breakthrough in lung cancer first-line treatment. However, there are few reports on st... read more here.
Keywords: predictive factors; treatment; factors combined; lung cancer ... See more keywords